Lurie Moves To FDA, Becomes Third Public Citizen Staffer With Key Role
This article was originally published in The Tan Sheet
Executive Summary
FDA's appointment of consumer advocate Peter Lurie to an Office of the Commissioner policy post suggests a strategy of bringing in some of the most outspoken critics of both the drug industry and FDA to address public perceptions of the agency
You may also be interested in...
FDA Strengthens Capitol Hill Muscle With Legislative Office Appointment
The appointment of House Energy and Commerce Committee staff veteran Jeanne Ireland to FDA's newly elevated legislation office further hones the agency's ability to influence lawmakers
FDA Report Calls For Dedicated Office Component For Dispute Management
FDA should create a unit within the commissioner's office dedicated to managing disputes between companies or other entities and the agency's centers, a report by agency staffers says
FDA Commissioner Must Not Come From Agency, Stupak Advises Obama
Rep. Bart Stupak has called on the incoming administration to look outside FDA for the next commissioner - even to fill the post short-term on an acting basis